ProQR Therapeutics (PRQR) Assets Average (2014 - 2026)

ProQR Therapeutics has reported Assets Average for 12 years, with the latest figure at $123.6 million in Q1 2026.

• Quarterly Assets Average fell 27.09% year-over-year to $123.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123.6 million (down 27.09% YoY) and the FY2025 annual result came in at $155.4 million, down 5.22% from the prior year.
• Assets Average fell to $123.6 million in Q1 2026 per PRQR's latest filing, from $138.3 million in the prior quarter.
• Over five years, Assets Average peaked at $226.6 million in Q1 2022 and troughed at $122.2 million in Q3 2024.
• A 5-year average of $156.7 million and a median of $151.5 million in 2023 frame the typical range for Assets Average.
• The sharpest annual moves came in 2022 and 2025: Assets Average tumbled 99.63% in 2022, then gained 23.15% in 2025.
• Over 5 years, Assets Average stood at $148.8 million in 2022, then grew by 1.83% to $151.5 million in 2023, then dropped by 2.03% to $148.4 million in 2024, then retreated by 6.81% to $138.3 million in 2025, then decreased by 10.64% to $123.6 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $123.6 million, $138.3 million, and $150.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.